Mutations in the TP53 gene appear to influence the prognosis and likelihood of future cancers in pediatric leukemia patients.

More than 200 people are on waiting lists for the $373,000 treatment as hospitals try to work around problems with insurers. 

High levels of vitamin C absorbed by blood-forming stem cells are important for their normal development.